
Gemini Therapeutics (GMTX) Market Capitalization Overview
Market Cap: $3.04B as of Dec 24, 2025
$3.04B
$516.43M (14.54%)past month
As of Dec 24, 2025, Gemini Therapeutics (GMTX) has a market capitalization of $3.04B. Over the past 30 days, its market cap has increased by 9.32%, while in the last 12 months, it has increased by 60.93%.
Market capitalization represents the total value of Gemini Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Gemini Therapeutics (GMTX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Gemini Therapeutics (GMTX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Gemini Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Gemini Therapeutics (GMTX) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of Gemini Therapeutics (GMTX) helps investors assess the company's size and compare it with competitors for better investment decisions.
Gemini Therapeutics (GMTX) Market Cap & Key Trends
See Gemini Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in Gemini Therapeutics (GMTX)
Order type
Buy in
Order amount
Est. shares
0 shares
Gemini Therapeutics (GMTX) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $3.47B | +9.32% |
| Nov 3, 2025 | $3.17B | +35.84% |
| Oct 1, 2025 | $2.34B | +9.19% |
| Sep 2, 2025 | $2.14B | +4.52% |
| Aug 1, 2025 | $2.05B | +15.33% |
| Jul 1, 2025 | $1.78B | +7.12% |
| Jun 2, 2025 | $1.66B | -3.92% |
| May 1, 2025 | $1.73B | +5.56% |
| Apr 1, 2025 | $1.63B | -13.22% |
| Mar 3, 2025 | $1.88B | -0.40% |
| Feb 3, 2025 | $1.89B | +1.47% |
| Jan 2, 2025 | $1.86B | -2.76% |
Gemini Therapeutics (GMTX) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2025 | $3.04B | +60.93% |
| 2024 | $1.89B | +35.31% |
| 2023 | $1.40B | +1,519.03% |
| 2022 | $86.13M | -31.51% |
| 2021 | $125.74M | -26.42% |
| 2020 | $170.89M | — |
FAQs About Gemini Therapeutics (GMTX) Market Cap
As of Dec 24, 2025, the market capitalization of Gemini Therapeutics (GMTX) is $3.04B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Gemini Therapeutics’s market capitalization has decreased by -14.54%, changing from $3.56B to $3.04B as of Dec 24, 2025.
In the last 3 months, Gemini Therapeutics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Gemini Therapeutics’s market capitalization increased from $1.40B in January to $1.89B in December, reflecting a 35.31% change.
In the past five years, Gemini Therapeutics (GMTX) has had a compound annual growth rate (CAGR) of 61.66% in market capitalization. This means its market cap has grown at an average rate of 61.66% per year.